In Declining for ~3 weeks · since 11 Sep 2026stage history
Price10-week line30-week trend line252 trading days
Relative strength vs the F&O universe RS line· baseline 100
The RS line is below its peak and not rising — this stock isn’t out-leading the universe right now, whatever its price is doing.
Returns
3M
-3.3%
6M
-8.0%
9M
-23.0%
12M
-22.2%
52-week range
₹806₹1175
-28.5% from its 52-week high
Trend-health checklist1/5
✕Price above the 30-week line
✕30-week line is rising
✓10-week line above the 30-week line
✕Price above the 10-week line
✕Strength rank 70 or higher
Extension & risk
Above 30-week line
-7.3%
Below the line
30-week line (floor)
₹906
structural floor
Risk back to floor
7.9%
if it returns there
10-week line
₹925
nearer support
If price slid back to its 30-week line from here, that is 7.9% — the structural risk this far above the line. These are levels read from the price series, not a buy or sell call.
Futures positioning
Flatcurrent-month future · 27 days to expiry
Flat: little change in futures price or open interest since the prior session.
Basis (future vs cash)
-1.05%
discount · ₹8.8
Open interest
+0.1%
vs prior session
Future price
₹832
cash ₹840
Futures move
-0.1%
today
Read from the current-month futures contract. Around monthly expiry these reads turn noisy as positions roll to the next series. Descriptive of positioning, not a buy or sell call.
Options positioning
current-month option chain · 20 strikes near the money · 27 days to expiry
ATM implied volatility
32.7%
call 33% · put 33%
Expected move to expiry
±8.9%
~ ±₹74 (1SD)
Put/call ratio (OI)
0.97
by volume 0.68
Max pain
₹880
ATM ₹840
Read from the current-month option strikes around the money. Implied volatility is solved from the at-the-money call and put; the expected move is the one-standard-deviation range those prices imply to expiry. Near expiry these compress as time value decays. Descriptive of option pricing, not a buy or sell call.
The 30-week line is computed live from adjusted prices; the checklist is computed from that same series, so chart and score always agree. Educational analysis only — not a recommendation, and not investment advice.